Neurovalens receives EU MDR compliance for sleep insomnia gadget
Northern Irish firm Neurovalens has acquired EU Medical Gadget Regulation (MDR) compliance for its prescription insomnia gadget, Modius Sleep.
This product is now accredited on the market in Europe and the UK.
Uncover B2B advertising that delivers
Mix enterprise intelligence and editorial excellence to achieve engaged professionals throughout 36 main media platforms.
Extra info
Neurovalens develops non-invasive medical units that focus on a wide range of well being situations, with an emphasis on at-home remedies for metabolic and psychological well being.
Often called electrical vestibular system stimulation (VSS), Modius expertise makes use of low-level electrical indicators to non-invasively stimulate particular areas of the mind related to psychological well being.
Modius Sleep is designed to deal with insomnia by making use of a protected electrical pulse to the person’s head for half-hour earlier than bedtime. Throughout remedy, customers can proceed different actions comparable to studying or watching tv.
Attaining MDR compliance demonstrates that Modius Sleep meets the stringent security, scientific analysis and high quality administration requirements required for entry to the EU market.
The gadget can be registered with the UK Medicines and Healthcare merchandise Regulator Company (MHRA), making it appropriate on the market in each the EU and the UK.
Beforehand, Neurovalens acquired approval from the US Meals and Drug Administration (FDA) for each Modius Sleep and Modius Calm, the anxiousness administration gadget.
Following regulatory approval, these units are actually being prescribed by U.S. healthcare professionals.
Neurovalens CEO Dr. Jason McKeown stated: “Receiving this approval for Modius Sleep from European and UK regulators is one other necessary milestone for Neurovalens as we proceed our mission to offer a low-risk, non-invasive therapeutic different to present remedies for power well being situations comparable to insomnia and anxiousness.
“Most different sleep-related merchandise available on the market measure the signs of insomnia, however Modius Sleep is a non-invasive gadget that truly treats the underlying drawback, which might have a transformative influence on the lives of our sufferers.”
In April 2024, Neurovalens acquired FDA approval for its Modius Stress gadget, designed to deal with generalized anxiousness dysfunction.
